![Impax to pay $35 million to settle part of Solodyn antitrust litigation]( "Impax to pay $35 million to settle part of Solodyn antitrust litigation")
Impax Laboratories Inc has agreed to pay $35 million to resolve part of litigation over claims it entered into an anticompetitive deal in a patent case to delay releasing a generic version of the acne medication Solodyn. The settlement was disclosed in papers filed in federal court in Boston on Saturday. It resolved part of the antitrust litigation Impax faces over Solodyn related to sales of the drug to direct purchasers such as retailers and wholesalers.
from Yahoo News - Latest News & Headlines http://ift.tt/2DhHg6G
No comments:
Post a Comment